Literature DB >> 34221831

A case of interstitial pneumonia associated with systemic sclerosis and primary peritoneal serous carcinoma successfully treated with cyclophosphamide.

Shunichi Kawamura1, Toshio Kubo2, Kenji Takada3, Ryota Sunami3, Sachi Okawa3, Yoshitaka Iwamoto3,4, Atsuko Hirabae3, Akihiko Taniguchi3, Yoshinobu Maeda5, Katsuyuki Kiura3, Masahiro Tabata2.   

Abstract

A 62-year-old woman with edema and color changes in her fingers underwent computed tomography (CT); slight interstitial changes were detected in the lungs with multiple tumors in the anterior and hilar region of the liver. Based on the blood test findings, she was diagnosed with interstitial pneumonia associated with systemic sclerosis. Ultrasound-guided biopsy from the hepatic hilar lymph node revealed poorly differentiated serous adenocarcinoma cells. High serum CA-125 levels suggested primary peritoneal serous carcinoma (PPSC). Owing to increased interstitial shadows on chest CT images and worsening respiratory distress, intravenous cyclophosphamide and oral prednisolone treatment was started. The skin-related symptoms, respiratory distress, and interstitial shadows improved, and the tumor size reduced. Eighteen months later, the patient has had no exacerbation of interstitial pneumonia, and the PPSC is well controlled. © The Japan Society of Clinical Oncology 2021.

Entities:  

Keywords:  Cyclophosphamide; Interstitial pneumonia; Primary peritoneal serous carcinoma; Systemic sclerosis

Year:  2021        PMID: 34221831      PMCID: PMC8206247          DOI: 10.1007/s13691-021-00475-1

Source DB:  PubMed          Journal:  Int Cancer Conf J        ISSN: 2192-3183


  8 in total

1.  Changes in causes of death in systemic sclerosis, 1972-2002.

Authors:  Virginia D Steen; Thomas A Medsger
Journal:  Ann Rheum Dis       Date:  2007-02-28       Impact factor: 19.103

Review 2.  Summary of the Japanese Respiratory Society statement for the treatment of lung cancer with comorbid interstitial pneumonia.

Authors:  Takashi Ogura; Nagio Takigawa; Keisuke Tomii; Kazuma Kishi; Yoshikazu Inoue; Eiki Ichihara; Sakae Homma; Kazuhisa Takahashi; Hiroaki Akamatsu; Satoshi Ikeda; Naohiko Inase; Tae Iwasawa; Yuichiro Ohe; Hiromitsu Ohta; Hiroshi Onishi; Isamu Okamoto; Kazumasa Ogawa; Kazuo Kasahara; Hiroki Karata; Takumi Kishimoto; Yuka Kitamura; Akihiko Gemma; Hirotsugu Kenmotsu; Hiroyuki Sakashita; Susumu Sakamoto; Katsutoshi Sekine; Yuichi Takiguchi; Yuji Tada; Shinichi Toyooka; Yuko Nakayama; Yasuhiko Nishioka; Koichi Hagiwara; Masaki Hanibuchi; Junya Fukuoka; Yuji Minegishi; Toyoshi Yanagihara; Nobuyuki Yamamoto; Hiromasa Yamamoto; Mina Gaga; Kwun M Fong; Charles A Powell; Katsuyuki Kiura
Journal:  Respir Investig       Date:  2019-08-01

3.  Effect of platinum-based chemotherapy for non-small cell lung cancer patients with interstitial lung disease.

Authors:  Hirotsugu Kenmotsu; Tateaki Naito; Keita Mori; Ryo Ko; Akira Ono; Kazushige Wakuda; Hisao Imai; Tetsuhiko Taira; Haruyasu Murakami; Masahiro Endo; Toshiaki Takahashi
Journal:  Cancer Chemother Pharmacol       Date:  2015-01-07       Impact factor: 3.333

4.  Treatment of 126 cases of advanced ovarian carcinoma with cyclophosphamide.

Authors:  R E Beck; D A Boyes
Journal:  Can Med Assoc J       Date:  1968-03-16       Impact factor: 8.262

5.  Cyclophosphamide is associated with pulmonary function and survival benefit in patients with scleroderma and alveolitis.

Authors:  B White; W C Moore; F M Wigley; H Q Xiao; R A Wise
Journal:  Ann Intern Med       Date:  2000-06-20       Impact factor: 25.391

6.  Exacerbation of idiopathic interstitial pneumonias associated with lung cancer therapy.

Authors:  Yuji Minegishi; Kiyoshi Takenaka; Hideki Mizutani; Junko Sudoh; Rintaro Noro; Tetsuya Okano; Arata Azuma; Akinobu Yoshimura; Masahiro Ando; Eitaka Tsuboi; Shoji Kudoh; Akihiko Gemma
Journal:  Intern Med       Date:  2009-05-01       Impact factor: 1.271

7.  Therapy for severe interstitial lung disease in systemic sclerosis. A retrospective study.

Authors:  V D Steen; J K Lanz; C Conte; G R Owens; T A Medsger
Journal:  Arthritis Rheum       Date:  1994-09

8.  Clinical characteristics of primary peritoneal carcinoma.

Authors:  Sang Young Roh; Sook Hee Hong; Yoon Ho Ko; Tae Hee Kim; Myung Ah Lee; Byoung Yong Shim; Jae Ho Byun; In Sook Woo; Jin Hyoung Kang; Young Seon Hong; Kyung Shik Lee
Journal:  Cancer Res Treat       Date:  2007-06-30       Impact factor: 4.679

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.